Evidence-Based Medicine Guidelines
Hydroxyurea for sickle cell disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hydroxyurea for Sickle Cell Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454434/all/Hydroxyurea_for_sickle_cell_disease.
Hydroxyurea for sickle cell disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/454434/all/Hydroxyurea_for_sickle_cell_disease. Accessed November 23, 2024.
Hydroxyurea for sickle cell disease. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454434/all/Hydroxyurea_for_sickle_cell_disease
Hydroxyurea for Sickle Cell Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454434/all/Hydroxyurea_for_sickle_cell_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hydroxyurea for sickle cell disease
ID - 454434
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454434/all/Hydroxyurea_for_sickle_cell_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
